
A new study suggests that a pill called colchicine might lower the chance of needing knee or hip replacement surgery.
Let’s take a closer look at what this means and how it might help those living with joint problems.
Osteoarthritis is one of the most common joint conditions, especially among older adults. It happens when the joints—such as those in the knees and hips—wear down over time. This wear and tear can lead to inflammation, stiffness, and pain. Being overweight or having a past injury can make things worse.
Doctors and researchers have been exploring ways to slow down the damage caused by osteoarthritis. Since inflammation seems to play a big role in this condition, scientists are testing treatments that reduce inflammation. One of those treatments is colchicine.
Colchicine is a medication that has been used for many years to treat gout, another painful condition caused by inflammation. It’s known for calming inflammation and reducing the thickening and scarring of tissue. Although colchicine is not commonly used for osteoarthritis right now, researchers are starting to explore its potential benefits.
In a recent study led by researchers at Sint Maartenskliniek and Radboud University Medical Center in the Netherlands, more than 5,500 people aged 35 to 82 took part in a trial across 43 locations in Australia and the Netherlands.
Half of the participants took a small daily dose of colchicine (0.5 mg), while the other half took a placebo—a pill with no medicine. The study lasted around 29 months.
The results were encouraging. Only 2.5% of people who took colchicine needed joint replacement surgery during the study period, compared to 3.5% of those who took the placebo. That means fewer people on colchicine had to undergo knee or hip surgeries.
The benefit was especially clear for men, though the results for women weren’t as conclusive. More studies will be needed to see how effective colchicine is for women with osteoarthritis.
So, what does all this mean? The findings support the idea that inflammation helps drive the damage caused by osteoarthritis. By reducing inflammation, colchicine may help slow down the disease and delay or even prevent surgery.
Another important point is that colchicine has been used safely for many years to treat other conditions. This gives doctors confidence that it could be safe for longer-term use in people with osteoarthritis.
Still, the researchers say more studies are needed before colchicine can be widely recommended for joint problems. They want to make sure it works well and is safe for everyone, including women.
In the meantime, people with osteoarthritis should continue with healthy habits like staying active, eating nutritious foods, and following their doctor’s advice to protect their joints.
There are other exciting developments in the world of pain management too. Some researchers are studying why certain cholesterol drugs cause muscle pain.
Others are developing new tools to treat pain without using medications. Some studies suggest that aspirin might help prevent serious complications in bone fractures, while certain painkillers might make joint inflammation worse.
This new research on colchicine was published in the Annals of Internal Medicine and could lead to better ways to manage joint pain in the future.
If you care about pain, please read studies about Chronic morphine use for cancer pain may increase bone loss and findings of Scientists find a new hope for chronic pain.
For more about pain, please read studies about What you need to know about diabetes and joint pain and findings of Understanding the connection between liver disease and joint pain.
Copyright © 2025 Knowridge Science Report. All rights reserved.